

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive thymic T cell selection (GO:0045059) | 6.63148294 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.08707194 |
| 3 | positive T cell selection (GO:0043368) | 6.04642040 |
| 4 | response to interleukin-15 (GO:0070672) | 5.87159977 |
| 5 | negative T cell selection (GO:0043383) | 5.76302026 |
| 6 | negative thymic T cell selection (GO:0045060) | 5.72064872 |
| 7 | tolerance induction (GO:0002507) | 5.61347957 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 5.59864144 |
| 9 | thymic T cell selection (GO:0045061) | 5.58363280 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.52295303 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.39716309 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.39716309 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.27397874 |
| 14 | T cell selection (GO:0045058) | 5.19734013 |
| 15 | regulation of regulatory T cell differentiation (GO:0045589) | 5.17899860 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.05196485 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.88671620 |
| 18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.69014497 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.66837690 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.65022255 |
| 21 | cellular response to type I interferon (GO:0071357) | 4.65022255 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.64082020 |
| 23 | response to type I interferon (GO:0034340) | 4.58946409 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.57494365 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 4.43696852 |
| 26 | response to interferon-beta (GO:0035456) | 4.37217486 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26726152 |
| 28 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.19607381 |
| 29 | cellular response to interferon-beta (GO:0035458) | 4.18246748 |
| 30 | leukocyte aggregation (GO:0070486) | 4.13566773 |
| 31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.11228300 |
| 32 | T cell costimulation (GO:0031295) | 4.10688377 |
| 33 | lymphocyte costimulation (GO:0031294) | 4.04931929 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.04196948 |
| 35 | hepatocyte apoptotic process (GO:0097284) | 3.91594660 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.87794281 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.80885741 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.79967708 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74549775 |
| 40 | detection of bacterium (GO:0016045) | 3.73170438 |
| 41 | T cell migration (GO:0072678) | 3.71230306 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.70555106 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64035762 |
| 44 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.61406223 |
| 45 | positive regulation of defense response to virus by host (GO:0002230) | 3.54921287 |
| 46 | natural killer cell differentiation (GO:0001779) | 3.54868473 |
| 47 | detection of other organism (GO:0098543) | 3.48147907 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43316299 |
| 49 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.42343150 |
| 50 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.41280320 |
| 51 | interferon-gamma production (GO:0032609) | 3.40690893 |
| 52 | positive regulation of interleukin-2 production (GO:0032743) | 3.39495331 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.38716626 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.37252506 |
| 55 | positive regulation of granulocyte differentiation (GO:0030854) | 3.37122991 |
| 56 | granulocyte activation (GO:0036230) | 3.36538047 |
| 57 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.32681687 |
| 58 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.32291096 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.27475755 |
| 60 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26222345 |
| 61 | megakaryocyte development (GO:0035855) | 3.25194401 |
| 62 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.24224942 |
| 63 | negative regulation of innate immune response (GO:0045824) | 3.24205529 |
| 64 | mast cell activation (GO:0045576) | 3.22125498 |
| 65 | positive regulation of protein oligomerization (GO:0032461) | 3.21835749 |
| 66 | cellular response to interferon-gamma (GO:0071346) | 3.17065093 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 3.15081506 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 3.12646190 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.12531654 |
| 70 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.10970381 |
| 71 | leukocyte degranulation (GO:0043299) | 3.08973791 |
| 72 | regulation of B cell differentiation (GO:0045577) | 3.06417691 |
| 73 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05900511 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05070970 |
| 75 | negative regulation of T cell apoptotic process (GO:0070233) | 3.02777515 |
| 76 | angiogenesis involved in wound healing (GO:0060055) | 2.99218531 |
| 77 | T cell homeostasis (GO:0043029) | 2.96839536 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.96387945 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 2.96387945 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96387945 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.96387945 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.96387945 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 2.96387945 |
| 84 | cellular defense response (GO:0006968) | 2.95630021 |
| 85 | alpha-beta T cell differentiation (GO:0046632) | 2.94017500 |
| 86 | activated T cell proliferation (GO:0050798) | 2.93863830 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.93806531 |
| 88 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.93639343 |
| 89 | regulation of alpha-beta T cell activation (GO:0046634) | 2.93591839 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 2.92221616 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90122178 |
| 92 | regulation of interleukin-1 secretion (GO:0050704) | 2.89604034 |
| 93 | negative regulation of viral genome replication (GO:0045071) | 2.89248272 |
| 94 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.88542230 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86804869 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86804869 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.86717421 |
| 98 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85824221 |
| 99 | regulation of isotype switching (GO:0045191) | 2.84583535 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83513808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.62798213 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.56339561 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.68420459 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.53652664 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.48401131 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.00446758 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95117137 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42021280 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.17573525 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12391274 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.98064818 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.97314004 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79143666 |
| 14 | MYB_26560356_Chip-Seq_TH1_Human | 2.76245791 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71878412 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.51033049 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.42360637 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41904190 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.40508606 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32904260 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23359869 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14428347 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.14035807 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13303499 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11838999 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09517221 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08224762 |
| 28 | GATA3_26560356_Chip-Seq_TH2_Human | 2.02856656 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91394305 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81006202 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.78613024 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75276364 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73713134 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67728575 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63632955 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62499784 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61738623 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53672519 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52880993 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48075897 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46679094 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44398464 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42515717 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41279880 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40773709 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38076279 |
| 47 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34487035 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31569774 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31496564 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30370275 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30051920 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29489431 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28026680 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23956983 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23493918 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.20970878 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20002232 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17478583 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12305875 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12100462 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10931626 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08425528 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08177645 |
| 64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.06963619 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04175916 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04058327 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02738445 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02600616 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01324964 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98957731 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93186837 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92125255 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92112029 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91913583 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90717275 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89564024 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89538899 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89172471 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87983872 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85849994 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85079678 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82603750 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82017375 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81176324 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80593458 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77887846 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76866458 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76529974 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76377185 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74939566 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73954312 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72667772 |
| 93 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70259071 |
| 94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.70112319 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69960324 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.69411796 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69318449 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68904932 |
| 99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68194628 |
| 100 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.66792238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.69031903 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.81445298 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.57962758 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.54235422 |
| 5 | MP0001800_abnormal_humoral_immune | 3.27140360 |
| 6 | MP0005387_immune_system_phenotype | 3.13362435 |
| 7 | MP0001790_abnormal_immune_system | 3.13362435 |
| 8 | MP0003436_decreased_susceptibility_to | 2.96636122 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.94225334 |
| 10 | MP0009840_abnormal_foam_cell | 2.91585189 |
| 11 | MP0009785_altered_susceptibility_to | 2.88076243 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.72983368 |
| 13 | MP0002723_abnormal_immune_serum | 2.70730042 |
| 14 | MP0005025_abnormal_response_to | 2.68790858 |
| 15 | MP0001873_stomach_inflammation | 2.67028850 |
| 16 | MP0003724_increased_susceptibility_to | 2.63398601 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.56685694 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.55825025 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.52550779 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.52540309 |
| 21 | MP0001819_abnormal_immune_cell | 2.50754117 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.48000876 |
| 23 | MP0002405_respiratory_system_inflammati | 2.41948686 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.34168886 |
| 25 | MP0000685_abnormal_immune_system | 2.27889973 |
| 26 | MP0002398_abnormal_bone_marrow | 2.20241952 |
| 27 | MP0006082_CNS_inflammation | 2.19127898 |
| 28 | MP0002009_preneoplasia | 2.17653884 |
| 29 | MP0000703_abnormal_thymus_morphology | 2.14424046 |
| 30 | MP0000716_abnormal_immune_system | 2.11448133 |
| 31 | MP0002419_abnormal_innate_immunity | 2.05331761 |
| 32 | MP0002102_abnormal_ear_morphology | 2.00383845 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.98524938 |
| 34 | MP0002006_tumorigenesis | 1.97055616 |
| 35 | MP0003866_abnormal_defecation | 1.88669142 |
| 36 | MP0005310_abnormal_salivary_gland | 1.83382208 |
| 37 | MP0009764_decreased_sensitivity_to | 1.81964579 |
| 38 | MP0002933_joint_inflammation | 1.80484641 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.78109090 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.77592096 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.74102850 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.73832647 |
| 43 | MP0003303_peritoneal_inflammation | 1.72190353 |
| 44 | MP0002722_abnormal_immune_system | 1.70484121 |
| 45 | MP0002429_abnormal_blood_cell | 1.63686279 |
| 46 | MP0003787_abnormal_imprinting | 1.54785864 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.51153187 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.46540743 |
| 49 | MP0004947_skin_inflammation | 1.39992796 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.39108636 |
| 51 | MP0008469_abnormal_protein_level | 1.25829827 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.18899878 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.18159381 |
| 54 | MP0001853_heart_inflammation | 1.12626516 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.09955641 |
| 56 | MP0001851_eye_inflammation | 1.06097196 |
| 57 | MP0004381_abnormal_hair_follicle | 1.05092394 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.04146456 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.01149933 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.98808409 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.95649435 |
| 62 | MP0005174_abnormal_tail_pigmentation | 0.88790382 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.88166453 |
| 64 | MP0000371_diluted_coat_color | 0.86799611 |
| 65 | MP0000604_amyloidosis | 0.84474580 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.83484140 |
| 67 | MP0003045_fibrosis | 0.81742350 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81690338 |
| 69 | MP0000858_altered_metastatic_potential | 0.80744159 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.79977152 |
| 71 | MP0001663_abnormal_digestive_system | 0.79088682 |
| 72 | MP0008260_abnormal_autophagy | 0.77658988 |
| 73 | MP0003448_altered_tumor_morphology | 0.76498382 |
| 74 | MP0009763_increased_sensitivity_to | 0.74660459 |
| 75 | MP0005670_abnormal_white_adipose | 0.66753611 |
| 76 | MP0004510_myositis | 0.64780607 |
| 77 | MP0002132_abnormal_respiratory_system | 0.59715169 |
| 78 | MP0005166_decreased_susceptibility_to | 0.57505067 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.57213313 |
| 80 | MP0005390_skeleton_phenotype | 0.54925350 |
| 81 | MP0003075_altered_response_to | 0.54361706 |
| 82 | MP0000249_abnormal_blood_vessel | 0.53366037 |
| 83 | MP0005365_abnormal_bile_salt | 0.53029769 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.51837508 |
| 85 | MP0008873_increased_physiological_sensi | 0.49775643 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.49015068 |
| 87 | MP0003646_muscle_fatigue | 0.47119554 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.44676688 |
| 89 | MP0003315_abnormal_perineum_morphology | 0.44514828 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.43916072 |
| 91 | MP0002163_abnormal_gland_morphology | 0.43573481 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.40868771 |
| 93 | MP0005266_abnormal_metabolism | 0.40636371 |
| 94 | MP0001243_abnormal_dermal_layer | 0.39774039 |
| 95 | MP0005408_hypopigmentation | 0.39769922 |
| 96 | MP0000609_abnormal_liver_physiology | 0.38068100 |
| 97 | MP0000920_abnormal_myelination | 0.36531242 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.36310490 |
| 99 | MP0009278_abnormal_bone_marrow | 0.36183223 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.35855328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune hemolytic anemia (HP:0001890) | 7.03929018 |
| 2 | Stomatitis (HP:0010280) | 5.91468384 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83517414 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 4.42319658 |
| 5 | Abnormality of the prostate (HP:0008775) | 4.28605079 |
| 6 | Pulmonary infiltrates (HP:0002113) | 4.24355841 |
| 7 | IgG deficiency (HP:0004315) | 4.23439423 |
| 8 | Obstructive lung disease (HP:0006536) | 4.11531088 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.11531088 |
| 10 | Meningitis (HP:0001287) | 4.03974703 |
| 11 | Hemoptysis (HP:0002105) | 3.90690472 |
| 12 | Chest pain (HP:0100749) | 3.88439972 |
| 13 | Papilledema (HP:0001085) | 3.84044407 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.78784337 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.74085155 |
| 16 | T lymphocytopenia (HP:0005403) | 3.64399050 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61534323 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.58737559 |
| 19 | Albinism (HP:0001022) | 3.48924115 |
| 20 | IgM deficiency (HP:0002850) | 3.37417916 |
| 21 | Vasculitis (HP:0002633) | 3.36350928 |
| 22 | Abnormality of T cells (HP:0002843) | 3.35779032 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.27022841 |
| 24 | Encephalitis (HP:0002383) | 3.25185811 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.24010458 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.21820042 |
| 27 | Chronic diarrhea (HP:0002028) | 3.21193582 |
| 28 | Pulmonary fibrosis (HP:0002206) | 3.20285458 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.17376677 |
| 30 | Myositis (HP:0100614) | 3.13656189 |
| 31 | Pulmonary embolism (HP:0002204) | 3.09084625 |
| 32 | Ureteral stenosis (HP:0000071) | 3.05478299 |
| 33 | Joint swelling (HP:0001386) | 3.03745289 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.01292192 |
| 35 | Optic neuritis (HP:0100653) | 3.01292192 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.99127099 |
| 37 | Increased IgM level (HP:0003496) | 2.94006477 |
| 38 | Ureteral obstruction (HP:0006000) | 2.88197593 |
| 39 | Gangrene (HP:0100758) | 2.86266440 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83686471 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83686471 |
| 42 | Orchitis (HP:0100796) | 2.82830090 |
| 43 | Lymphopenia (HP:0001888) | 2.80530132 |
| 44 | Eosinophilia (HP:0001880) | 2.78715307 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.78557493 |
| 46 | Abnormality of the pleura (HP:0002103) | 2.76379439 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.74662971 |
| 48 | Papilloma (HP:0012740) | 2.71737645 |
| 49 | Verrucae (HP:0200043) | 2.71737645 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.70505953 |
| 51 | Spondylolisthesis (HP:0003302) | 2.69958502 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.68112694 |
| 53 | Pustule (HP:0200039) | 2.63745432 |
| 54 | Epistaxis (HP:0000421) | 2.63135445 |
| 55 | Fair hair (HP:0002286) | 2.61662659 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.60796582 |
| 57 | Leukocytosis (HP:0001974) | 2.59564483 |
| 58 | Granulocytopenia (HP:0001913) | 2.57623697 |
| 59 | Recurrent bronchitis (HP:0002837) | 2.55321394 |
| 60 | Skin rash (HP:0000988) | 2.54664983 |
| 61 | IgA deficiency (HP:0002720) | 2.52089866 |
| 62 | Respiratory difficulties (HP:0002880) | 2.51377433 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.47592533 |
| 64 | Recurrent skin infections (HP:0001581) | 2.47300267 |
| 65 | Abnormality of male internal genitalia (HP:0000022) | 2.43178518 |
| 66 | Glomerulopathy (HP:0100820) | 2.38093959 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37342308 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37342308 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37342308 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.37328875 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.35896352 |
| 72 | Premature loss of primary teeth (HP:0006323) | 2.33802225 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.33759938 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.33100301 |
| 75 | Axonal loss (HP:0003447) | 2.32590103 |
| 76 | Abnormality of the pericardium (HP:0001697) | 2.30381760 |
| 77 | Keratitis (HP:0000491) | 2.30214656 |
| 78 | Hypoproteinemia (HP:0003075) | 2.28428476 |
| 79 | Lipid accumulation in hepatocytes (HP:0006561) | 2.25131267 |
| 80 | Polyneuropathy (HP:0001271) | 2.21923313 |
| 81 | Arterial thrombosis (HP:0004420) | 2.20326185 |
| 82 | Urticaria (HP:0001025) | 2.20247066 |
| 83 | Mucosal telangiectasiae (HP:0100579) | 2.19553538 |
| 84 | Abnormality of the fingertips (HP:0001211) | 2.17985149 |
| 85 | Hypochromic anemia (HP:0001931) | 2.17524354 |
| 86 | Recurrent viral infections (HP:0004429) | 2.14419287 |
| 87 | Keratoconjunctivitis (HP:0001096) | 2.14365548 |
| 88 | Generalized hypopigmentation of hair (HP:0011358) | 2.13350368 |
| 89 | Gingivitis (HP:0000230) | 2.11992416 |
| 90 | Restrictive lung disease (HP:0002091) | 2.09447262 |
| 91 | Hip dysplasia (HP:0001385) | 2.09279188 |
| 92 | Periodontitis (HP:0000704) | 2.07804866 |
| 93 | Slow saccadic eye movements (HP:0000514) | 2.07690518 |
| 94 | Ocular albinism (HP:0001107) | 2.07113026 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.06946845 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.06167047 |
| 97 | Diplopia (HP:0000651) | 2.04754758 |
| 98 | Abnormality of binocular vision (HP:0011514) | 2.04754758 |
| 99 | Exertional dyspnea (HP:0002875) | 2.03118047 |
| 100 | Combined immunodeficiency (HP:0005387) | 2.01791544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.21935386 |
| 2 | MAP4K1 | 4.42739286 |
| 3 | DMPK | 3.38168715 |
| 4 | JAK3 | 3.19802945 |
| 5 | ITK | 2.98402577 |
| 6 | TYK2 | 2.92371018 |
| 7 | FES | 2.54879192 |
| 8 | TNK2 | 2.42929419 |
| 9 | BTK | 2.22175760 |
| 10 | IKBKE | 2.10595973 |
| 11 | MST4 | 2.10002230 |
| 12 | LCK | 2.03044241 |
| 13 | JAK1 | 1.86046676 |
| 14 | TEC | 1.84887618 |
| 15 | STK16 | 1.84236082 |
| 16 | RIPK4 | 1.82653335 |
| 17 | ZAP70 | 1.82021287 |
| 18 | SIK3 | 1.81368474 |
| 19 | HCK | 1.79861741 |
| 20 | SYK | 1.71967985 |
| 21 | MAP3K12 | 1.47762081 |
| 22 | LYN | 1.46176991 |
| 23 | IKBKB | 1.41764402 |
| 24 | CSK | 1.41162356 |
| 25 | FGFR4 | 1.40404686 |
| 26 | FGFR3 | 1.31071272 |
| 27 | IRAK4 | 1.26660192 |
| 28 | KIT | 1.26035015 |
| 29 | CAMKK2 | 1.26020934 |
| 30 | GRK6 | 1.24224974 |
| 31 | EIF2AK1 | 1.22270272 |
| 32 | TBK1 | 1.20079922 |
| 33 | JAK2 | 1.19477767 |
| 34 | BLK | 1.16816056 |
| 35 | FYN | 1.15029250 |
| 36 | CDK4 | 1.05404894 |
| 37 | TRIM28 | 1.04606606 |
| 38 | NLK | 0.99424873 |
| 39 | CDK8 | 0.93282279 |
| 40 | CSF1R | 0.89546127 |
| 41 | TAOK3 | 0.88974339 |
| 42 | CDK6 | 0.87343656 |
| 43 | STK10 | 0.86717583 |
| 44 | PASK | 0.82930537 |
| 45 | MAPKAPK3 | 0.80282740 |
| 46 | RPS6KC1 | 0.78789595 |
| 47 | RPS6KL1 | 0.78789595 |
| 48 | MAP3K14 | 0.76523703 |
| 49 | RPS6KA5 | 0.75609888 |
| 50 | IGF1R | 0.75304049 |
| 51 | CAMKK1 | 0.75035375 |
| 52 | MARK3 | 0.74586615 |
| 53 | RPS6KA6 | 0.74263298 |
| 54 | MAP2K3 | 0.73377163 |
| 55 | TLK1 | 0.71616087 |
| 56 | PRKCQ | 0.71510311 |
| 57 | MELK | 0.69507268 |
| 58 | CDK9 | 0.68763146 |
| 59 | BRD4 | 0.66845453 |
| 60 | CLK1 | 0.66546428 |
| 61 | MAP3K11 | 0.66404169 |
| 62 | IRAK1 | 0.63816025 |
| 63 | ZAK | 0.63400114 |
| 64 | ADRBK2 | 0.58145087 |
| 65 | PIK3CG | 0.57094730 |
| 66 | GRK7 | 0.55244283 |
| 67 | PIM1 | 0.55087173 |
| 68 | FGFR2 | 0.53180251 |
| 69 | EPHB1 | 0.53073024 |
| 70 | IRAK2 | 0.53014655 |
| 71 | PRPF4B | 0.52917122 |
| 72 | RPS6KA2 | 0.52311675 |
| 73 | PTK2B | 0.51685386 |
| 74 | SIK2 | 0.50940617 |
| 75 | MAPK11 | 0.50274860 |
| 76 | MAP3K3 | 0.49753590 |
| 77 | SGK3 | 0.47580691 |
| 78 | MAP3K13 | 0.47479212 |
| 79 | MAPKAPK2 | 0.45378954 |
| 80 | OXSR1 | 0.43141027 |
| 81 | BUB1 | 0.41941010 |
| 82 | MAP2K6 | 0.38717416 |
| 83 | STK38 | 0.38225719 |
| 84 | MATK | 0.37655571 |
| 85 | MAPK12 | 0.37366640 |
| 86 | CDK3 | 0.37225571 |
| 87 | TYRO3 | 0.36604820 |
| 88 | STK24 | 0.36286407 |
| 89 | PRKCH | 0.33937850 |
| 90 | LRRK2 | 0.33585227 |
| 91 | EGFR | 0.33559427 |
| 92 | PDK1 | 0.31670785 |
| 93 | GRK5 | 0.29916129 |
| 94 | RET | 0.29909696 |
| 95 | CSNK1D | 0.29580365 |
| 96 | FRK | 0.28517758 |
| 97 | BCR | 0.27155882 |
| 98 | FGR | 0.26898093 |
| 99 | STK39 | 0.26275994 |
| 100 | PIK3CA | 0.24973135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.31306883 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.11316886 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95824729 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.60270911 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.21692770 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.09310654 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.08419838 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.90440809 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.73122779 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.70910132 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.53506535 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.47855052 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39487924 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.37970211 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18083631 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09783009 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03373501 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.84393067 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70263976 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64082573 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62916218 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60454652 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58801841 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55270947 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46579624 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.46222567 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40939991 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38874732 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32808208 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27460306 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.23279379 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.20034200 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17184274 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09095687 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04874040 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02125831 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01498201 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 0.98437187 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97003014 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91540858 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90446330 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88450327 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.86821364 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.81199779 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80849238 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.79486264 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78903816 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78166151 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.78042628 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77741627 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.76232176 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72788497 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.70776815 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69994983 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65821433 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.64867942 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64233587 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60197282 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.55722889 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55087954 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52641105 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.52581353 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51434217 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.50674110 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48558665 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37303969 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35465313 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34488673 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33198964 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30315217 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29140390 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29111353 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29062811 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28158817 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26633167 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26428255 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26037321 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24647174 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22118974 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21464504 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21024622 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18473291 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17863293 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16846718 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.15005060 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13990386 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11370299 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.10764674 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09730391 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.09679320 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09161289 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08601904 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.07585351 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06593423 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05568497 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.05442207 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.04405517 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.03248321 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02444995 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.01842894 |

